IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,175,000 | +56.7% | 306,494 | +74.4% | 0.19% | +96.9% |
| Q2 2022 | $2,026,000 | +392.9% | 175,714 | +438.3% | 0.10% | +326.1% |
| Q1 2022 | $411,000 | -87.2% | 32,643 | -88.2% | 0.02% | -80.8% |
| Q4 2021 | $3,218,000 | +76.5% | 275,966 | +97.7% | 0.12% | +27.7% |
| Q3 2021 | $1,823,000 | +8.3% | 139,579 | +6.8% | 0.09% | +30.6% |
| Q2 2021 | $1,683,000 | +32.7% | 130,745 | +15.3% | 0.07% | +1.4% |
| Q1 2021 | $1,268,000 | +106.5% | 113,392 | +110.4% | 0.07% | +39.2% |
| Q4 2020 | $614,000 | +10.6% | 53,895 | -12.7% | 0.05% | -15.0% |
| Q3 2020 | $555,000 | -14.1% | 61,737 | -1.4% | 0.06% | -43.9% |
| Q2 2020 | $646,000 | +17.5% | 62,583 | +14.9% | 0.11% | +59.7% |
| Q1 2020 | $550,000 | +259.5% | 54,488 | +374.8% | 0.07% | +415.4% |
| Q4 2019 | $153,000 | -26.8% | 11,475 | -53.0% | 0.01% | 0.0% |
| Q3 2019 | $209,000 | -35.7% | 24,400 | +1.7% | 0.01% | -73.5% |
| Q1 2019 | $325,000 | – | 24,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |